Advertisement

CERT

Certara, Inc.

Healthcare · USD

Set alert

Price alert · CERT

All alert types
11.02 USD -0.18 -1.61%
As of Oct 30, 2026 Extended hours 11.08 +0.54%
Bid
11.00 × 2
Ask
11.02 × 2
10.65 Day range 11.19
4.48 52-week range 11.70
YTD
+25.09%
1 year
-2.99%
Open
11.07
Prev close
11.20
Mkt cap
1.68B
Vol
1.95M
Avg vol
2.82M
EPS
-0.14
P/E
0.00
Div yield
0.00%
More statistics
Low
10.65
High
11.19
Forward P/E
27.27
Beta
1.43
Short ratio
8.41
Inst. own
111.12%
Dividend
0.00
Ex-div date
Earnings
Nov 5, 2026
50-d avg
8.97
200-d avg
7.26
1y target
9.17

5m chart

Chart tools
Interval
CERT five-minute interval price chart9.8610.310.811.311.7Oct 22Oct 23Oct 26Oct 27Oct 28

Built from the cached five-day intraday bars.

Key statistics

Market cap
1.63B
Enterprise value
1.83B
Trailing P/E
0.00
Forward P/E
27.27
PEG ratio
0.00
Price / sales
3.86
Price / book
1.68
EPS (TTM)
-0.14
Beta
1.43
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-16.22%
Revenue (TTM)
421.75M
Revenue growth
1.00%
Free cash flow
62.58M
Total cash
184.87M
Total debt
301.94M
Return on equity
-2.21%
Shares outstanding
152.54M
Short % of float
26.37%
50-day average
8.97
200-day average
7.26

Analyst view

Consensus: buy

Buy
Price target (mean) 9.17 -16.8% downside
Target (low)
7.00
Target (mean)
9.17
Target (high)
12.00
Ratings (0m) 13 4 buy · 9 hold · 0 sell
  • Strong buy0
  • Buy4
  • Hold9
  • Sell0
  • Strong sell0

Next earnings

Nov 5, 2026

Expected Nov 5, 2026. Consensus EPS estimate 0.0864.

Earnings history

Financials — quick view

All financials
CERT Revenue — quarterly 93.27M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CERT Net income — quarterly -55.27M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
CERT EPS — quarterly -0.36
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

CERT recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 5, 2026Sep 30, 20260.08656———
Aug 4, 2026Jun 30, 20260.08930.08-0.01-10.41%
May 11, 2026Mar 31, 20260.110.09-0.02-18.18%
Feb 26, 2026Dec 31, 20250.110.09-0.02-18.18%
Nov 6, 2025Sep 30, 20250.110.14+0.03+27.27%
Aug 6, 2025Jun 30, 20250.100.07-0.03-30.00%

Upgrades / downgrades

CERT analyst upgrades and downgrades
DateFirmActionFromTo
Oct 16, 2026KeybancmainOverweightOverweight
Oct 13, 2026TD CowenmainBuyBuy
Oct 7, 2026BarclaysmainEqual-WeightEqual-Weight
Sep 30, 2026UBSdownBuyNeutral
Aug 5, 2026BarclaysmainEqual-WeightEqual-Weight
May 12, 2026Craig-HallummainHoldHold

About Certara, Inc.

Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Sector
Healthcare
Industry
Health Information Services
Country
United States
Website
certara.com

News

Your note

Sign in to keep a note on CERT — it syncs with the Stock Master app.

Insider holders

CERT insider holders
InsiderRelationLatest transactionDateShares held
ASPBURY ROBERTOfficerConversion of Exercise of derivative securityMar 31, 2026332,442
BROSHY ERANChairman of the BoardConversion of Exercise of derivative securityMay 13, 202650,708
CASHMAN JAMES E IIIChairman of the BoardConversion of Exercise of derivative securityMay 13, 2026484,197
COLLINS CYNTHIADirectorConversion of Exercise of derivative securityMay 13, 202651,846
CRANE ROSEMARY ADirectorConversion of Exercise of derivative securityMay 13, 202645,672
FEEHERY WILLIAM F.Chief Executive OfficerPurchaseNov 10, 20252,360,770

Institution ownership

CERT institution ownership
Holder% heldSharesValueReported
Blackrock Inc.12.34%18,818,180200.88MJun 29, 2026
Deerfield Management Company, L.P4.93%7,512,92880.20MJun 29, 2026
Haveli Investment Management LLC4.85%7,400,00079.00MJun 29, 2026
Jefferies Financial Group Inc.4.65%7,091,05175.70MJun 29, 2026
Vanguard Portfolio Management LLC4.63%7,056,10675.32MJun 29, 2026
Dimensional Fund Advisors LP3.95%6,022,68664.29MJun 29, 2026

Fund ownership

CERT fund ownership
Holder% heldSharesValueReported
iShares Trust-iShares Core S&P Small-Cap ETF4.40%6,716,94071.70MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.44%3,721,80539.73MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.01%3,060,35732.67MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.75%2,673,18628.54MJun 29, 2026
Touchstone Strategic TRT-Touchstone Strategic TRT-Touchstone Small Com1.44%2,195,40723.44MJun 29, 2026
WASATCH FUNDS TRUST-Wasatch Small Cap Value Fund1.19%1,814,40619.37MJun 29, 2026
Advertisement